Curated for Europe. Designed for Impact.
7-9 September, 2026
InterContinental Barcelona
2025 Event Highlights
Entering its 6th year, Advanced Therapies Europe 2026 remains an intentionally intimate gathering for senior decision-makers, designed to deliver real impact with each and every conversation . Returning to Barcelona in 2026, the centre of Europe’s dynamic and fast-growing biotech ecosystem, where strategic connections spark progress and insights translate into action. Whether your goal is to invest, scale, partner, or launch, Advanced Therapies Europe 2026 is the platform to make it happen.
Who is Advanced Therapies Europe for?
Advanced Therapies Europe is a focused conference and networking event for the advanced therapies and regenerative medicine community. It brings together key people across European biotech and life sciences to discuss innovation, investment and bringing new treatments to market.
The event will take place on 7-9 September 2026 at InterContinental Barcelona, Spain.
If you work in cell and gene therapy, regenerative medicine, biotech investment or manufacturing, this event is designed for you. It is ideal for senior leaders, scientists, investors, regulators and solution providers involved in the future of advanced therapies in Europe.
Yes! Advanced Therapies Europe is an intimate event designed for early-stage biotechs and startups looking to breakthrough to the next stage of development. In 2025, we had a record $1bn+ active investment fund in the room, with nearly 1000 curated meetings taking place via our networking app. The format prioritises quality over scale, so you spend less time searching and more time progressing deals, partnerships and funding conversations.
Unlike larger exhibitions, this event focuses on in-depth discussion, targeted networking and knowledge sharing. It is smaller and more selective, with around 600 senior attendees, designed to encourage meaningful conversations and connections.
Sessions explore a wide range of issues across the advanced therapies field, including clinical development, commercial strategy, regulatory planning, manufacturing, market access and patient involvement.
Yes. The event includes a one-to-one partnering system so you can arrange meetings with potential collaborators, investors or clients before and during the event.
Yes. The event is built to help you meet deal makers, funders and biotech leaders from across the sector. It is a valuable chance to connect with people who influence the direction of advanced therapies in Europe.
Registration is currently not live for 2026, but you can register your interest to be among the first to be notified of pre-sale opportunities.
Who you'll meet at ATE 2026
Explore the organisations already registered for Advanced Therapies Europe 2026, from therapeutic developers and pharma to investors, CDMOs, regulators and solution providers.
2026 Attendee List 2026 Exhibitor List
600 senior leaders. One European ecosystem.
)
)
)
)
)
)
)
)
)
)
Advanced Therapies Europe News
)
)
)
![[Whitepaper] The Science Is Proven. The Systems Are Not](https://cdn.asp.events/CLIENT_CL_Conf_BDA05934_5056_B731_4C9EEBBE0C2416C2/sites/phacilitate-2025/media/libraries/insights-resources/Phac26_Whitepaper-Carousel_1080x1080px_v2-1-1.png/fit-in/500x500/filters:no_upscale())
)
)
)
